Cancer Fighters Thrive®
10109 E. 79th Street
Tulsa, OK 74133
SANCUSO® (Granisetron Transdermal System):
A recommendation from
leading treatment guidelines1,2
When preparing for chemotherapy, be
armed
&
ready
For nausea and vomiting
One patch.
One application.
5 days of coverage.3,4
Visit www.sancuso.com to learn
more and to download a moneysaving copay card.
Please refer to the sunlight warning in
the important safety information below.
Important safety information
SANCUSO® (Granisetron Transdermal System) is indicated for the prevention of nausea and vomiting in patients receiving moderately and/or highly emetogenic chemotherapy regimens of up to
5 consecutive days duration.4 Do not use SANCUSO if you are allergic to granisetron or any of the other ingredients in SANCUSO.4 Tell your healthcare professional if you are pregnant, if you plan
to become pregnant, or you are breastfeeding.4 Tell your healthcare professional if you have pain or swelling in stomach area (abdomen), or if you are allergic to medical adhesive tape, adhesive
dressings, or other skin patches.4 Tell your healthcare professional about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Other
medicines may affect how SANCUSO works. SANCUSO may also affect how your other medicines work.4 The medicine in SANCUSO (granisetron) may not work well and/or may affect your skin if
exposed to direct sunlight and the light from sunlamps or tanning beds. While wearing the patch keep it covered with clothing if you will be in sunlight or near a sunlamp, including tanning beds.
Keep the skin where SANCUSO was applied covered for another 10 days after the patch is taken off to protect from exposure to direct sunlight.4 You may see mild redness on the skin where the
patch is removed. This redness should go away within three days. If redness continues, tell your healthcare professional. The most common side effect of SANCUSO is constipation.4 Tell your
healthcare professional if you have any side effect that bothers you or that does not go away. This is not the only possible side effect of SANCUSO.4 For more information, ask your healthcare
professional or pharmacist.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
References:
1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Antiemesis. V.1.2012. http://www.nccn.org/professionals/physician_
gls/pdf/antiemesis.pdf. Accessed December 13, 2011. 2. Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of Clinical Oncology Clinical
Practice Guideline Update. J Clin Oncol. 2011;29(31):4189-4198. 3. Boccia RV, Gordan LN, Clark G, Howell JD, Grunberg SM; on behalf of the Sancuso Study
Group. Efficacy and tolerability of transdermal granisetron for the control of chemotherapy-induced nausea and vomiting associated with moderately and highly
emetogenic multi-day chemotherapy: a randomized, double-blind, phase III study. Support Care Cancer. 2011;19(10):1609-1617. 4. SANCUSO [package insert].
Bridgewater, NJ: ProStrakan, Inc; 2012.
ONLY
®
1-800-SANCUSO
www.sancuso.com
SANCUSO is a registered trademark of ProStrakan, Inc.
©2012 ProStrakan, Inc.
All rights reserved. Printed in U.S.A. SAN-2012-006R1 July 2012
48 cancer fighters thrive | spring 2013
Please see brief summary of
Prescribing Information on adjacent page.
Keeps them covered
cfthrive.com